Feasibility assessment of yttrium-90 liver radioembolization imaging using amplitude-based gated PET/CT

Dustin Osborne, Shelley N. Acuff, Melissa L. Neveu, Mumtaz Syed, Austin D. Kaman, Yitong Fu

Research output: Contribution to journalArticle

Abstract

Purpose The usage of PET/computed tomography (CT) to monitor hepatocellular carcinoma patients following yttrium-90 (90 Y) radioembolization has increased. Respiratory motion causes liver movement, which can be corrected using gating techniques at the expense of added noise. This work examines the use of amplitude-based gating on 90 Y-PET/CT and its potential impact on diagnostic integrity. Patients and methods Patients were imaged using PET/CT following 90 Y radioembolization. A respiratory band was used to collect respiratory cycle data. Patient data were processed as both standard and motion-corrected images. Regions of interest were drawn and compared using three methods. Activity concentrations were calculated and converted into dose estimates using previously determined and published scaling factors. Diagnostic assessments were performed using a binary scale created from published 90 Y-PET/CT image interpretation guidelines. Results Estimates of radiation dose were increased (P<0.05) when using amplitude-gating methods with 90 Y PET/CT imaging. Motion-corrected images show increased noise, but the diagnostic determination of success, using the Kao criteria, did not change between static and motion-corrected data. Conclusion Amplitude-gated PET/CT following 90 Y radioembolization is feasible and may improve 90 Y dose estimates while maintaining diagnostic assessment integrity.

Original languageEnglish (US)
Pages (from-to)222-227
Number of pages6
JournalNuclear Medicine Communications
Volume39
Issue number3
DOIs
StatePublished - Jan 1 2018

Fingerprint

Yttrium
Tomography
Liver
Noise
Hepatocellular Carcinoma
Guidelines
Radiation

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Cite this

Feasibility assessment of yttrium-90 liver radioembolization imaging using amplitude-based gated PET/CT. / Osborne, Dustin; Acuff, Shelley N.; Neveu, Melissa L.; Syed, Mumtaz; Kaman, Austin D.; Fu, Yitong.

In: Nuclear Medicine Communications, Vol. 39, No. 3, 01.01.2018, p. 222-227.

Research output: Contribution to journalArticle

Osborne, Dustin ; Acuff, Shelley N. ; Neveu, Melissa L. ; Syed, Mumtaz ; Kaman, Austin D. ; Fu, Yitong. / Feasibility assessment of yttrium-90 liver radioembolization imaging using amplitude-based gated PET/CT. In: Nuclear Medicine Communications. 2018 ; Vol. 39, No. 3. pp. 222-227.
@article{3e6bdc1b2d304f949e57740bc1a46659,
title = "Feasibility assessment of yttrium-90 liver radioembolization imaging using amplitude-based gated PET/CT",
abstract = "Purpose The usage of PET/computed tomography (CT) to monitor hepatocellular carcinoma patients following yttrium-90 (90 Y) radioembolization has increased. Respiratory motion causes liver movement, which can be corrected using gating techniques at the expense of added noise. This work examines the use of amplitude-based gating on 90 Y-PET/CT and its potential impact on diagnostic integrity. Patients and methods Patients were imaged using PET/CT following 90 Y radioembolization. A respiratory band was used to collect respiratory cycle data. Patient data were processed as both standard and motion-corrected images. Regions of interest were drawn and compared using three methods. Activity concentrations were calculated and converted into dose estimates using previously determined and published scaling factors. Diagnostic assessments were performed using a binary scale created from published 90 Y-PET/CT image interpretation guidelines. Results Estimates of radiation dose were increased (P<0.05) when using amplitude-gating methods with 90 Y PET/CT imaging. Motion-corrected images show increased noise, but the diagnostic determination of success, using the Kao criteria, did not change between static and motion-corrected data. Conclusion Amplitude-gated PET/CT following 90 Y radioembolization is feasible and may improve 90 Y dose estimates while maintaining diagnostic assessment integrity.",
author = "Dustin Osborne and Acuff, {Shelley N.} and Neveu, {Melissa L.} and Mumtaz Syed and Kaman, {Austin D.} and Yitong Fu",
year = "2018",
month = "1",
day = "1",
doi = "10.1097/MNM.0000000000000794",
language = "English (US)",
volume = "39",
pages = "222--227",
journal = "Nuclear Medicine Communications",
issn = "0143-3636",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Feasibility assessment of yttrium-90 liver radioembolization imaging using amplitude-based gated PET/CT

AU - Osborne, Dustin

AU - Acuff, Shelley N.

AU - Neveu, Melissa L.

AU - Syed, Mumtaz

AU - Kaman, Austin D.

AU - Fu, Yitong

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Purpose The usage of PET/computed tomography (CT) to monitor hepatocellular carcinoma patients following yttrium-90 (90 Y) radioembolization has increased. Respiratory motion causes liver movement, which can be corrected using gating techniques at the expense of added noise. This work examines the use of amplitude-based gating on 90 Y-PET/CT and its potential impact on diagnostic integrity. Patients and methods Patients were imaged using PET/CT following 90 Y radioembolization. A respiratory band was used to collect respiratory cycle data. Patient data were processed as both standard and motion-corrected images. Regions of interest were drawn and compared using three methods. Activity concentrations were calculated and converted into dose estimates using previously determined and published scaling factors. Diagnostic assessments were performed using a binary scale created from published 90 Y-PET/CT image interpretation guidelines. Results Estimates of radiation dose were increased (P<0.05) when using amplitude-gating methods with 90 Y PET/CT imaging. Motion-corrected images show increased noise, but the diagnostic determination of success, using the Kao criteria, did not change between static and motion-corrected data. Conclusion Amplitude-gated PET/CT following 90 Y radioembolization is feasible and may improve 90 Y dose estimates while maintaining diagnostic assessment integrity.

AB - Purpose The usage of PET/computed tomography (CT) to monitor hepatocellular carcinoma patients following yttrium-90 (90 Y) radioembolization has increased. Respiratory motion causes liver movement, which can be corrected using gating techniques at the expense of added noise. This work examines the use of amplitude-based gating on 90 Y-PET/CT and its potential impact on diagnostic integrity. Patients and methods Patients were imaged using PET/CT following 90 Y radioembolization. A respiratory band was used to collect respiratory cycle data. Patient data were processed as both standard and motion-corrected images. Regions of interest were drawn and compared using three methods. Activity concentrations were calculated and converted into dose estimates using previously determined and published scaling factors. Diagnostic assessments were performed using a binary scale created from published 90 Y-PET/CT image interpretation guidelines. Results Estimates of radiation dose were increased (P<0.05) when using amplitude-gating methods with 90 Y PET/CT imaging. Motion-corrected images show increased noise, but the diagnostic determination of success, using the Kao criteria, did not change between static and motion-corrected data. Conclusion Amplitude-gated PET/CT following 90 Y radioembolization is feasible and may improve 90 Y dose estimates while maintaining diagnostic assessment integrity.

UR - http://www.scopus.com/inward/record.url?scp=85043530943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043530943&partnerID=8YFLogxK

U2 - 10.1097/MNM.0000000000000794

DO - 10.1097/MNM.0000000000000794

M3 - Article

VL - 39

SP - 222

EP - 227

JO - Nuclear Medicine Communications

JF - Nuclear Medicine Communications

SN - 0143-3636

IS - 3

ER -